Insider · CIK 0001432063

Avelar Rui

Reports to the SEC for 2 companies · NEWPORT BEACH

sec.gov

Transactions

Companies

Filings

CIK

0001432063

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-20	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−3,119 sh	$4.75	−$14.8K	427,423
2026-03-17	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−30K sh	$4.89	−$147K	430,542
2026-03-16	EOLSEvolus, Inc. · Performance Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−8,804 sh	—	—	8,802
2026-03-16	EOLSEvolus, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+8,804 sh	—	—	460,538
2026-02-17	EOLSEvolus, Inc.A Award	See Remarks	AAward	+94.9K sh	—	—	451,734
2026-02-17	EOLSEvolus, Inc. · Performance Restricted Stock UnitsA Award	See Remarks	AAward	+94.9K sh	—	—	94,913
2026-02-17	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+139K sh	—	—	138,649
2025-12-22	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−2,261 sh	$7.15	−$16.2K	356,821
2025-05-12	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−3,385 sh	$9.87	−$33.4K	359,082
2025-03-18	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−27.9K sh	$13.26	−$370K	362,467
2025-03-07	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+33.9K sh	—	—	33,875
2025-03-07	EOLSEvolus, Inc. · Performance Restricted Stock UnitsA Award	See Remarks	AAward	+23.8K sh	—	—	23,776
2025-03-07	EOLSEvolus, Inc.A Award	See Remarks	AAward	+23.8K sh	—	—	390,371
2024-12-23	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−2,252 sh	$10.85	−$24.4K	366,595
2024-05-10	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−3,441 sh	$12.72	−$43.8K	368,847
2024-03-19	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−27.6K sh	$13.92	−$384K	372,288
2024-02-22	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−1,821 sh	$13.08	−$23.8K	399,891
2024-02-21	EOLSEvolus, Inc.A Award	See Remarks	AAward	+13.1K sh	—	—	401,712
2024-02-07	EOLSEvolus, Inc. · Performance Restricted Stock UnitsA Award	See Remarks	AAward	+17.6K sh	—	—	17,606
2024-02-07	EOLSEvolus, Inc.A Award	See Remarks	AAward	+35.2K sh	—	—	388,597
2024-02-07	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+47.3K sh	—	—	47,337
2023-08-16	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−2,211 sh	$10.27	−$22.7K	353,386
2023-08-14	EOLSEvolus, Inc.A Award	See Remarks	AAward	+19.7K sh	—	—	355,597
2023-03-14	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−14.9K sh	$8.47	−$126K	335,925
2023-01-25	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+85.7K sh	—	—	85,670
2023-01-25	EOLSEvolus, Inc.A Award	See Remarks	AAward	+97.6K sh	—	—	350,831
2022-03-08	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−10.2K sh	$9.73	−$99.1K	253,189
2022-01-24	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+77.6K sh	—	—	77,640
2022-01-24	EOLSEvolus, Inc.A Award	See Remarks	AAward	+53.6K sh	—	—	263,381
2021-08-10	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−14.3K sh	$11.18	−$160K	209,810
2021-01-27	EOLSEvolus, Inc.A Award	See Remarks	AAward	+90K sh	—	—	224,103
2021-01-25	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−2,699 sh	$7.46	−$20.1K	134,103
2020-05-13	EOLSEvolus, Inc.A Award	See Remarks	AAward	+40K sh	—	—	136,802
2020-01-23	EOLSEvolus, Inc.A Award	See Remarks	AAward	+26K sh	—	—	96,802
2020-01-23	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+45K sh	—	—	45,000
2020-01-07	EOLSEvolus, Inc.S Sale	See Remarks	SSale	−39.4K sh	$10.71	−$422K	70,802
2019-12-10	EOLSEvolus, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−10K sh	—	—	189,682
2019-12-10	EOLSEvolus, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+10K sh	$9.98	+$100K	110,244
2019-01-23	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+60K sh	—	—	60,000
2010-03-08	ANGIOTECH PHARMACEUTICALS INCStock Option w/Tandem SARA Award	Chief Medical Officer	AAward	+135K sh	—	—	790,000
2009-06-23	ANGIOTECH PHARMACEUTICALS INCAwards (Options w/Tandem SARs)J Other	Chief Medical Officer	JOther	−60K sh	—	—	655,000
2009-06-23	ANGIOTECH PHARMACEUTICALS INCOptionsJ Other	Chief Medical Officer	JOther	−200K sh	—	—	715,000
2009-03-10	ANGIOTECH PHARMACEUTICALS INCStock Option w/Tandem SARA Award	Chief Medical Officer	AAward	+200K sh	—	—	915,000

Recent filings

Accepted (ET)
Mar 204
Avelar Rui0001570562-26-000050
SEC(opens sec.gov)
Mar 184
Avelar Rui0001570562-26-000045
SEC(opens sec.gov)
Feb 194
Avelar Rui0001570562-26-000021
SEC(opens sec.gov)
Dec 294
Avelar Rui0001570562-25-000118
SEC(opens sec.gov)
May 144
Avelar Rui0001570562-25-000081
SEC(opens sec.gov)
Mar 204
Avelar Rui0001570562-25-000054
SEC(opens sec.gov)
Mar 114
Avelar Rui0001570562-25-000041
SEC(opens sec.gov)
Dec 264
Avelar Rui0001570562-24-000140
SEC(opens sec.gov)
May 144
Avelar Rui0001570562-24-000085
SEC(opens sec.gov)
Mar 214
Avelar Rui0001570562-24-000055
SEC(opens sec.gov)
Feb 234
Avelar Rui0001570562-24-000030
SEC(opens sec.gov)
Feb 94
Avelar Rui0001570562-24-000017
SEC(opens sec.gov)

Companies

Address

520 NEWPORT CENTER DR. SUITE 1200

NEWPORT BEACH, 92660